In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system

Karen Block, Andrew Kardana, Peter Igarashi, Hugh S. Taylor

Research output: Contribution to journalArticle

209 Citations (Scopus)

Abstract

Diethylstilbestrol (DES) was widely used to treat pregnant women through 1971. The reproductive tracts of their female offspring exposed to DES in utero are characterized by anatomic abnormalities. Here we show that DES administered to mice in utero produces changes in the expression pattern of several Hox genes that are involved in patterning of the reproductive tract. DES produces posterior shifts in Hox gene expression and homeotic anterior transformations of the reproductive tract. In human uterine or cervical cell cultures, DES induces HOXA9 or HOXA10 gene expression, respectively, to levels approximately twofold that induced by estradiol. The DES-induced expression is not inhibited by cyclohexamide. Estrogens are novel morphogens that directly regulate the expression pattern of posterior Hox genes in a manner analogous to retinoic acid regulation of anterior Hox genes. Alterations in HOX gene expression are a molecular mechanism by which DES affects reproductive tract development. Changes in Hox gene expression are a potential marker for the effects of in utero drug use that may become apparent only at late stages of development.

Original languageEnglish (US)
Pages (from-to)1101-1108
Number of pages8
JournalFASEB Journal
Volume14
Issue number9
StatePublished - 2000

Fingerprint

diethylstilbestrol
Diethylstilbestrol
Homeobox Genes
Gene expression
Gene Expression
gene expression
Genes
homeotic genes
genes
retinoic acid
pregnant women
Tretinoin
Cell culture
estrogens
estradiol
Pregnant Women
Estradiol
Estrogens
cell culture
Cell Culture Techniques

Keywords

  • Estrogens
  • Fetal development
  • Genes
  • Homeobox
  • Teratogens

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

Block, K., Kardana, A., Igarashi, P., & Taylor, H. S. (2000). In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB Journal, 14(9), 1101-1108.

In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. / Block, Karen; Kardana, Andrew; Igarashi, Peter; Taylor, Hugh S.

In: FASEB Journal, Vol. 14, No. 9, 2000, p. 1101-1108.

Research output: Contribution to journalArticle

Block, K, Kardana, A, Igarashi, P & Taylor, HS 2000, 'In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system', FASEB Journal, vol. 14, no. 9, pp. 1101-1108.
Block, Karen ; Kardana, Andrew ; Igarashi, Peter ; Taylor, Hugh S. / In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. In: FASEB Journal. 2000 ; Vol. 14, No. 9. pp. 1101-1108.
@article{8f55daa0e4874a4b8d1eb6622bda9a00,
title = "In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system",
abstract = "Diethylstilbestrol (DES) was widely used to treat pregnant women through 1971. The reproductive tracts of their female offspring exposed to DES in utero are characterized by anatomic abnormalities. Here we show that DES administered to mice in utero produces changes in the expression pattern of several Hox genes that are involved in patterning of the reproductive tract. DES produces posterior shifts in Hox gene expression and homeotic anterior transformations of the reproductive tract. In human uterine or cervical cell cultures, DES induces HOXA9 or HOXA10 gene expression, respectively, to levels approximately twofold that induced by estradiol. The DES-induced expression is not inhibited by cyclohexamide. Estrogens are novel morphogens that directly regulate the expression pattern of posterior Hox genes in a manner analogous to retinoic acid regulation of anterior Hox genes. Alterations in HOX gene expression are a molecular mechanism by which DES affects reproductive tract development. Changes in Hox gene expression are a potential marker for the effects of in utero drug use that may become apparent only at late stages of development.",
keywords = "Estrogens, Fetal development, Genes, Homeobox, Teratogens",
author = "Karen Block and Andrew Kardana and Peter Igarashi and Taylor, {Hugh S.}",
year = "2000",
language = "English (US)",
volume = "14",
pages = "1101--1108",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "9",

}

TY - JOUR

T1 - In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system

AU - Block, Karen

AU - Kardana, Andrew

AU - Igarashi, Peter

AU - Taylor, Hugh S.

PY - 2000

Y1 - 2000

N2 - Diethylstilbestrol (DES) was widely used to treat pregnant women through 1971. The reproductive tracts of their female offspring exposed to DES in utero are characterized by anatomic abnormalities. Here we show that DES administered to mice in utero produces changes in the expression pattern of several Hox genes that are involved in patterning of the reproductive tract. DES produces posterior shifts in Hox gene expression and homeotic anterior transformations of the reproductive tract. In human uterine or cervical cell cultures, DES induces HOXA9 or HOXA10 gene expression, respectively, to levels approximately twofold that induced by estradiol. The DES-induced expression is not inhibited by cyclohexamide. Estrogens are novel morphogens that directly regulate the expression pattern of posterior Hox genes in a manner analogous to retinoic acid regulation of anterior Hox genes. Alterations in HOX gene expression are a molecular mechanism by which DES affects reproductive tract development. Changes in Hox gene expression are a potential marker for the effects of in utero drug use that may become apparent only at late stages of development.

AB - Diethylstilbestrol (DES) was widely used to treat pregnant women through 1971. The reproductive tracts of their female offspring exposed to DES in utero are characterized by anatomic abnormalities. Here we show that DES administered to mice in utero produces changes in the expression pattern of several Hox genes that are involved in patterning of the reproductive tract. DES produces posterior shifts in Hox gene expression and homeotic anterior transformations of the reproductive tract. In human uterine or cervical cell cultures, DES induces HOXA9 or HOXA10 gene expression, respectively, to levels approximately twofold that induced by estradiol. The DES-induced expression is not inhibited by cyclohexamide. Estrogens are novel morphogens that directly regulate the expression pattern of posterior Hox genes in a manner analogous to retinoic acid regulation of anterior Hox genes. Alterations in HOX gene expression are a molecular mechanism by which DES affects reproductive tract development. Changes in Hox gene expression are a potential marker for the effects of in utero drug use that may become apparent only at late stages of development.

KW - Estrogens

KW - Fetal development

KW - Genes

KW - Homeobox

KW - Teratogens

UR - http://www.scopus.com/inward/record.url?scp=0034094901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034094901&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 1101

EP - 1108

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 9

ER -